期刊文献+

The epigenetics of CHARGE syndrome 被引量:1

The epigenetics of CHARGE syndrome
原文传递
导出
摘要 In biology, we continue to appreciate the fact that the DNA sequence alone falls short when attempting to explain the intricate inheritance patterns for complex traits. This is particularly true for human disorders that appear to have simple genetic causes. The study of epigenetics, and the increased access to the epigenetic profiles of different tissues has begun to shed light on the genetic complexity of many basic biological processes, both physiological and pathological. Epigenetics refers to heritable changes in gene expression that are not due to alterations in the DNA sequence. Various mechanisms of epigenetic regulation exist, including DNA methylation and histone modification. The identification, and increased understanding of key players and mechanisms of epigenetic regulation have begun to provide significant insight into the underlying origins of various human genetic disorders. One such disorder is CHARGE syndrome (OMIM #214800), which is a leading cause of deaf-blindness worldwide. A majority of CHARGE syndrome cases are caused by haploinsufficiency for the CHD7 gene, which encodes an ATP-dependent chromatin remodeling protein involved in the epigenetic regulation of gene expression. The CHD7 protein has been highly conserved throughout evolution, and research into the function of CHD7 homologs in multiple model systems has increased our understanding of this family of proteins, and epigenetic mechanisms in general. Here we provide a review of CHARGE syndrome, and discuss the epigenetic functions of CHD7 in humans and CHD7 homologs in model organisms. In biology, we continue to appreciate the fact that the DNA sequence alone falls short when attempting to explain the intricate inheritance patterns for complex traits. This is particularly true for human disorders that appear to have simple genetic causes. The study of epigenetics, and the increased access to the epigenetic profiles of different tissues has begun to shed light on the genetic complexity of many basic biological processes, both physiological and pathological. Epigenetics refers to heritable changes in gene expression that are not due to alterations in the DNA sequence. Various mechanisms of epigenetic regulation exist, including DNA methylation and histone modification. The identification, and increased understanding of key players and mechanisms of epigenetic regulation have begun to provide significant insight into the underlying origins of various human genetic disorders. One such disorder is CHARGE syndrome (OMIM #214800), which is a leading cause of deaf-blindness worldwide. A majority of CHARGE syndrome cases are caused by haploinsufficiency for the CHD7 gene, which encodes an ATP-dependent chromatin remodeling protein involved in the epigenetic regulation of gene expression. The CHD7 protein has been highly conserved throughout evolution, and research into the function of CHD7 homologs in multiple model systems has increased our understanding of this family of proteins, and epigenetic mechanisms in general. Here we provide a review of CHARGE syndrome, and discuss the epigenetic functions of CHD7 in humans and CHD7 homologs in model organisms.
出处 《Frontiers in Biology》 CAS CSCD 2016年第2期85-95,共11页 生物学前沿(英文版)
基金 Acknowledgeme nts We would like to thank Edward A. Waddell and Dr. Faith Liebl for critical reading of the manuscript, the CHARGE syndrome Foundation, and members of the CHARGE syndrome Foundation scientific advisory board for their work on CHARGE. Work in the Marenda laboratory is supported by a grant from the National Science Foundation (lOS 1256114) to DRM.
关键词 DROSOPHILA Kismet CHD7 CHARGE syndrome chromatin remodeling Drosophila, Kismet, CHD7, CHARGE syndrome, chromatin remodeling
分类号 Q [生物学]
  • 相关文献

参考文献73

  • 1Aalfs J D, Kingston R E (2000). What does chromatin remodeling mean? Trends Biochem Sci, 25(11): 548-555.
  • 2Allen M D, Religa T L, Freund S M, Bycroft M (2007). Solution structure of the BRK domains from CHD7. J Mol Biol, 371(5): 1135 1140.
  • 3Allis C D, Berger S L, Cote J, Dent S, Jenuwien T, Kouzarides T, Pillus L, Reinberg D, Shi Y, Shiekhattar R, Shilatifard A, Workman J, Zhang Y (2007). New nomenclature for chromatin- modifying enzymes. Cell, 131(4): 633536.
  • 4Bajpai R, Chen D A, Rada-Iglesias A, Zhang J, Xiong Y, Helms J, Chang C P, Zhao Y, Swigut T, Wysocka J (2010). CHD7 cooperates with PBAF to control multipotent neural crest formation. Nature, 463(7283): 958-962.
  • 5Balasubramanian D, Akhtar-Zaidi B, Song L, Bartels C F, Veigl M,Beard L, Myeroff L, Guda K, Lutterbaugh J, Willis J, Crawford G E, Markowitz S D, Scacheri P C (2012). H3K4me3 inversely correlates with DNA methylation at a large class of non-CpG-island- containing start sites. Genome Med, 4(5): 47.
  • 6Balow S A, Pierce L X, Zentner G E, Conrad P A, Davis S, Sabaawy H E, McDermott B MJr, Scacheri P C (2013). Knockdown of fbxll0/kdm2bb rescues chd7 morphant phenotype in a zebrafish model of CHARGE syndrome. Dev Biol, 382(1): 57-69.
  • 7Basson M A, van Ravenswaaij-Arts C (2015). Functional Insights into Chromatin remodelling from studies on CHARGE syndrome. Trends Genet, 31(10): 600-611.
  • 8Blake K D, Hartshorne T S, Lawand C, Dailor A N, Thelin J W (2008). Cranial nerve manifestations in CHARGE syndrome. Am J Med Genet A, 146A(5): 585-592.
  • 9Blake K D, Prasad C (2006). CHARGE syndrome. Orphanet J Rare Dis, 1(1): 34.
  • 10Bosman E A, Penn A C, Ambrose J C, Kettleborough R, Stemple D L, Steel K P (2005). Multiple mutations in mouse Chd7 provide models for CHARGE syndrome. Hum Mol Genet, 14(22): 3463-3476.

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部